Has Matthew Brown, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,759 in general payments to Matthew Brown, MD across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Brown, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Brown, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Brown, MD

Infectious Disease · Valdosta, GANPI 1275916827

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $16,650 of the $20,759 with a category attached, or 80.2%. AbbVie accounts for 93.1% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $18,642, more than ten times the $82 reported in 2020. Among infectious disease clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,759in general payments, 2019–2025

Across 117 payments — averaging $177.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$19K
Gilead$699
Inari Medical, Inc.$196
Merck$132
Paratek Pharmaceuticals, Inc.$118
Shionogi Inc$62
plus $215 from 8 others

What the payments were for

Speaking & faculty fees$16,65080%
Travel & lodging$1,3757%
Food & beverage$2,72013%
Education$140%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	80	$19,337
Gilead	12	$699
Inari Medical, Inc.	1	$196
Merck	7	$132
Paratek Pharmaceuticals, Inc.	4	$118
Shionogi Inc	2	$62
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$53
La Jolla Pharmaceutical Company	3	$47
KCI USA, Inc.	1	$26
Medtronic	1	$21
AstraZeneca	1	$20
Viiv Healthcare Company	1	$19
Biomerieux Inc	1	$15
Insmed, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,759 in reported general payments places this provider in the 90th percentile of 260 infectious disease providers in Georgia.

See all infectious disease providers in Georgia →

Medicare billing

Part B allowed, 2024

$98,013

Medicare patients

228

Services billed

861

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Daptomycin	84	$149,154
ErtapenemErtapenem Sodium	71	$23,470
Piperacillin-TazobactamPiperacillin Sodium/Tazobactam	34	$9,885
CeftriaxoneCeftriaxone Sodium	48	$4,051
Cefpodoxime Proxetil	26	$2,793
Doxycycline Hyclate	69	$2,387
Cefepime Hcl	12	$2,184
Methenamine Hippurate	22	$1,072
Rifampin	20	$738
Ethambutol Hcl	23	$557
Cephalexin	24	$429
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	23	$394
Clarithromycin	12	$356
Levofloxacin	22	$316
Fluconazole	11	$265

Paid to pharmacies, not to this prescriber.

Other infectious disease in Valdosta

Andrew DoldDacula$1.1M
Zandraetta Tims-CookAtlanta$848K
Jeffrey StephensMacon$356K
Jose VazquezAugusta$335K
Larry AndersonAtlanta$300K
Quintin RobinsonAtlanta$270K
James McMillenAtlanta$177K
Leandro MenaAtlanta$141K
Cheryl NewmanAugusta$128K
Colleen KraftAtlanta$103K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →